Mannkind (MNKD) Common Equity (2010 - 2026)
Mannkind (MNKD) reported Common Equity of -$59.2 million for Q1 2026, down 0.98% year-over-year from -$59.8 million in Q1 2025, and down 16.02% quarter-over-quarter from -$51.0 million in Q4 2025.
Mannkind (MNKD) Common Equity (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Common Equity data on file, last reported at -$59.2 million in Q1 2026.
- Common Equity for Q1 2026 came in at -$59.2 million, down 0.98% year-over-year; the trailing twelve-month figure through Mar 2026 was -$59.2 million (down 0.98% YoY), and the FY2025 annual result was -$51.0 million, up 35.26% from the prior year.
- Common Equity retreated to -$59.2 million in Q1 2026 per MNKD's latest filing, from -$51.0 million in the prior quarter.
- Over five years, Common Equity peaked at -$44.6 million in Q3 2025 and troughed at -$260.5 million in Q2 2023.
- A 5-year average of -$176.1 million and a median of -$230.0 million in 2024 frame the typical range for Common Equity.
- The sharpest annual moves came in 2022 and 2025: Common Equity sank 34.6% in 2022, then surged 78.78% in 2025.
- A 5-year view of Common Equity shows it stood at -$250.5 million in 2022, then rose by 1.74% to -$246.2 million in 2023, then soared by 67.98% to -$78.8 million in 2024, then surged by 35.26% to -$51.0 million in 2025, then dropped by 16.02% to -$59.2 million in 2026.
- Business Quant data shows MNKD's Common Equity at -$59.2 million in Q1 2026, -$51.0 million in Q4 2025, and -$44.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 13.21 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn | -59.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.20 Mn |
| Dec 31, 2025 | -51.02 Mn |
| Sep 30, 2025 | -44.55 Mn |
| Jun 30, 2025 | -55.04 Mn |
| Mar 31, 2025 | -58.62 Mn |
| Dec 31, 2024 | -78.82 Mn |
| Sep 30, 2024 | -209.93 Mn |
| Jun 30, 2024 | -225.78 Mn |
| Mar 31, 2024 | -229.97 Mn |
| Dec 31, 2023 | -246.17 Mn |
| Sep 30, 2023 | -251.78 Mn |
| Jun 30, 2023 | -260.49 Mn |
| Mar 31, 2023 | -255.40 Mn |
| Dec 31, 2022 | -250.54 Mn |
| Sep 30, 2022 | -237.68 Mn |
| Jun 30, 2022 | -247.06 Mn |
| Mar 31, 2022 | -232.06 Mn |
| Dec 31, 2021 | -209.35 Mn |
| Sep 30, 2021 | -184.69 Mn |
| Jun 30, 2021 | -183.55 Mn |